USFDA inspection at Solara’s Cuddalore facility concludes with Zero 483 observations EP News Bureau Aug 7, 2023 USFDA inspected the Cuddalore facility between July 31, 2023 – August 04, 2023
Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall Press Trust of India Jan 9, 2020 The company announced that the last supplies of the drug to the firm were made in September 2017 Amid the voluntary recall of…
